Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Regeneration of the endothelium as a novel therapeutic strategy for acute lung injury
Tohru Minamino, Issei Komuro
Tohru Minamino, Issei Komuro
View: Text | PDF
Commentary

Regeneration of the endothelium as a novel therapeutic strategy for acute lung injury

  • Text
  • PDF
Abstract

Acute lung injury (ALI) is characterized by the influx of protein-rich edematous fluid into the airspaces due to increased permeability of the alveolar-capillary barrier. Inflammatory mediators are thought to play a critical role in the pathogenesis of this disorder. In this issue of the JCI, Zhao et al. report that the forkhead box M1 (FoxM1) transcription factor induces endothelial regeneration and thereby restores endothelial barrier function after ALI (see the related article beginning on page 2333). Their findings raise the intriguing possibility that the promotion of endothelial regeneration may be a novel therapeutic strategy for ALI.

Authors

Tohru Minamino, Issei Komuro

×

Figure 2

Regulation of FoxM1 activity and its downstream target molecules.

Options: View larger image (or click on image) Download as PowerPoint
Regulation of FoxM1 activity and its downstream target molecules.
FoxM1 ...
FoxM1 is positively regulated by sonic hedgehog, Ras/MEK/ERK, and cyclin E/Cdk2 growth signaling pathways, among others, and inhibited by the tumor suppressor p19ARF. FoxM1 directly or indirectly modulates a number of cell cycle (replication/mitosis) regulators to promote cell proliferation and affects the signal pathways essential for organogenesis, including TGF-β signaling and VEGF signaling, thereby contributing to tissue regeneration, tumorigenesis, and organogenesis during embryonic development. Cdc25A, cell division cycle 25A; Cdc25B, cell division cycle 25B; CENP, centromere protein; Plk-1, polo-like kinase-1; p19ARF, 19-kDa alternative reading frame protein.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts